Case Control Study
Copyright ©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1753-1765
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1753
Figure 1
Figure 1 Correlation between microRNA 9-3p and endocan levels in the hepatocellular carcinoma group.
Figure 2
Figure 2 Receiver operating characteristic curve analysis of microRNA 9-3p, endocan and α-fetoprotein for discriminating between hepatocellular carcinoma and chronic liver disease.
Figure 3
Figure 3 Receiver operating characteristic curve analysis of microRNA 9-3p, endocan and α-fetoprotein for discriminating between hepatocellular carcinoma and control.